Advances in Antibody–Drug Conjugates for Treatment of Non-Small-Cell Lung Cancer

In this commentary, D. Ross Camidge, MD, PhD, provides his thoughts on the latest advances and potential of ADCs in the treatment of non-small-cell lung cancer.

D. Ross Camidge, MD, PhD Released: January 26, 2021

Download this slideset to gain expert insight into the current status of investigational antibody-drug conjugates for NSCLC.

D. Ross Camidge, MD, PhD Released: February 9, 2021

Download this slideset to gain expert insight into the activity of antibody-drug conjugates within the clinical trial setting for NSCLC.

Joel W. Neal, MD, PhD Released: February 16, 2021